Private Advisor Group’s Edwards Lifesciences EW Stock Holding History

Private Advisor Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.73M	Sell	21,610 -670	-3%	-$55.2K	0.01%	1117
2025 Q4	$1.9M	Sell	22,280 -1,321	-6%	-$108K	0.01%	1060
2025 Q3	$1.84M	Buy	23,601 +463	+2%	+$36.2K	0.01%	1052
2025 Q2	$1.81M	Sell	23,138 -663	-3%	-$49.4K	0.01%	1017
2025 Q1	$1.73M	Buy	23,801 +2,475	+12%	+$177K	0.01%	961
2024 Q4	$1.58M	Buy	21,326 +9,440	+79%	+$661K	0.01%	991
2024 Q3	$784K	Sell	11,886 -7,967	-40%	-$579K	﹤0.01%	1370
2024 Q2	$1.83M	Sell	19,853 -5,080	-20%	-$450K	0.01%	874
2024 Q1	$2.38M	Sell	24,933 -366	-1%	-$30.7K	0.02%	732
2023 Q4	$1.93M	Buy	25,299 +2,962	+13%	+$206K	0.02%	778
2023 Q3	$1.55M	Sell	22,337 -2,450	-10%	-$197K	0.01%	822
2023 Q2	$2.3M	Sell	24,787 -3,848	-13%	-$334K	0.02%	664
2023 Q1	$2.37M	Sell	28,635 -1,641	-5%	-$129K	0.02%	610
2022 Q4	$287K	Sell	30,276 -3,462	-10%	-$267K	0.01%	769
2022 Q3	$2.79M	Sell	33,738 -5,816	-15%	-$560K	0.03%	511
2022 Q2	$3.76M	Buy	39,554 +8,572	+28%	+$887K	0.03%	493
2022 Q1	$3.65M	Buy	30,982 +1,020	+3%	+$114K	0.03%	558
2021 Q4	$3.88M	Sell	29,962 -12,555	-30%	-$1.46M	0.03%	545
2021 Q3	$4.81M	Buy	42,517 +12,492	+42%	+$1.43M	0.03%	534
2021 Q2	$3.11M	Buy	30,025 +959	+3%	+$90.4K	0.03%	584
2021 Q1	$2.43M	Sell	29,066 -175	-0.6%	-$14.8K	0.02%	629
2020 Q4	$2.67M	Sell	29,241 -5,354	-15%	-$444K	0.03%	556
2020 Q3	$2.63M	Sell	34,595 -335	-1%	-$26.1K	0.03%	468
2020 Q2	$2.41M	Sell	34,930 -281	-0.8%	-$20K	0.03%	467
2020 Q1	$2.21M	Buy	35,211 +1,443	+4%	+$104K	0.04%	408
2019 Q4	$2.63M	Buy	33,768 +1,641	+5%	+$128K	0.04%	447
2019 Q3	$2.23M	Sell	32,127 -9,687	-23%	-$680K	0.03%	507
2019 Q2	$2.57M	Buy	+41,814	New	+$2.53M	0.05%	405
2019 Q1	–	Sell	-20,019	Closed	-$1.02M	–	1560
2018 Q4	$1.02M	Sell	20,019 -3,132	-14%	-$158K	0.02%	578
2018 Q3	$1.34M	Buy	23,151 +8,040	+53%	+$393K	0.03%	559
2018 Q2	$736K	Buy	15,111 +7,677	+103%	+$358K	0.01%	595
2018 Q1	$346K	Sell	7,434 -6,411	-46%	-$278K	0.01%	824
2017 Q4	$543K	Sell	13,845 -6,393	-32%	-$235K	0.02%	627
2017 Q3	$743K	Buy	20,238 +1,749	+9%	+$66.7K	0.02%	697
2017 Q2	$724K	Sell	18,489 -1,410	-7%	-$51.5K	0.02%	668
2017 Q1	$618K	Buy	+19,899	New	+$623K	0.02%	719
2016 Q4	–	Sell	-27,993	Closed	-$1.11M	–	1294
2016 Q3	$1.11M	Buy	+27,993	New	+$1.05M	0.05%	401
2016 Q2	–	Sell	-32,871	Closed	-$953K	–	1134
2016 Q1	$953K	Sell	32,871 -103,668	-76%	-$2.86M	0.05%	381
2015 Q4	$3.6M	Buy	136,539 +20,751	+18%	+$539K	0.17%	133
2015 Q3	$2.74M	Buy	115,788 +4,752	+4%	+$115K	0.15%	142
2015 Q2	$2.64M	Buy	111,036 +744	+0.7%	+$16.8K	0.13%	164
2015 Q1	$2.62M	Buy	110,292 +11,514	+12%	+$258K	0.15%	147
2014 Q4	$2.1M	Buy	98,778 +26,334	+36%	+$529K	0.14%	180
2014 Q3	$1.23M	Buy	72,444 +31,068	+75%	+$490K	0.09%	267
2014 Q2	$592K	Buy	+41,376	New	+$561K	0.05%	431

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Private Advisor Group's EW Position: Q1 2026 in Review

Private Advisor Group reduced its Edwards Lifesciences (EW) stake by 3% in Q1 2026, selling an estimated $55.2K and leaving 21,610 shares worth $1.73M. The position accounts for 0.01% of the portfolio, ranked #1117.

Private Advisor Group first reported a position in EW in Q2 2014 and has held it in 45 quarters since. The position peaked at $4.81M in Q3 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Private Advisor Group held 21,610 shares of Edwards Lifesciences worth $1.73M as of Q1 2026.
Private Advisor Group sold 670 Edwards Lifesciences shares in Q1 2026, an estimated $55.2K.
Edwards Lifesciences made up 0.01% of Private Advisor Group's portfolio in Q1 2026, its #1117 holding.
Private Advisor Group first reported a position in Edwards Lifesciences in Q2 2014 and has held it in 45 quarters since.
Private Advisor Group's Edwards Lifesciences position peaked at $4.81M in Q3 2021.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.